SCWorx Receives Nasdaq Hearings Panel Partial Compliance Letter for the Company’s Continued Listing on the Nasdaq Capital Market

SCWorx Corp. (WORX) announced receipt of a partial compliance letter from the Nasdaq Hearings Panel, signaling progress on its plan to maintain listing status on the Nasdaq Capital Market. The company has successfully completed the first benchmark in its approved compliance remediation roadmap, demonstrating operational alignment with exchange requirements.

This partial compliance milestone is procedural rather than transformative, reflecting the company's ability to execute against agreed-upon metrics rather than fundamental business improvements. For WORX, the letter represents a delisting risk reduction—the primary concern is no longer imminent removal, though full compliance remains outstanding. The continued uncertainty around reaching final compliance benchmarks maintains moderate overhang on investor sentiment.

SCWorx operates in healthcare supply chain data normalization, a niche technology subsector with structural tailwinds from healthcare digitization and supply chain modernization. Successful compliance preservation keeps the company positioned to capitalize on these secular trends, though near-term execution risk persists given the conditional nature of the Panel's approval.

Sector implication: The healthcare technology and supply chain optimization segments benefit from ongoing digitalization, but small-cap listings under compliance review typically trade with a conglomerate discount. WORX's news is company-specific rather than sector-driving, with minimal broad market correlation.